Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 30-Minute audio recording ease the pain of dialysis?

NCT ID NCT07837206

Symptom relief Sponsor: Jordan University of Science and Technology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 23, 2026 · Last updated Sep 24, 2026 · Updated 1 time

Summary

Researchers are testing whether a five-week mindfulness meditation program can reduce pain severity, pain catastrophizing, and improve quality of life for adults receiving hemodialysis. The trial enrolls 38 patients with chronic kidney disease stage 3-4 at a hospital in Saudi Arabia. Participants in the intervention group listen to a 30-minute audio recording three times a week during their dialysis sessions, while the control group receives standard care. The study measures changes in pain, quality of life, and trait mindfulness using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a five-week, audio-guided mindfulness meditation program
What this could lead to
If it helps, mindfulness audio could become a low-cost way to ease pain and distress for people on dialysis.
What could go wrong
The trial is small, with 38 participants at one hospital, so results may not apply broadly. Mindfulness may not reduce pain more than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

Jan 2025

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * being 18 years or older * Receiving maintenance hemodialysis for at least six months * being able to communicate in Arabic * Having smart phone Exclusion Criteria: * Having severe cognitive impairment or clinically significant psychiatric illness * concurrent enrollment in another structured psychological program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic kidney disease (stage 3-4) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease chronic renal failure syndrome end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic kidney disease (stage 3-4)

Contacts and locations

Locations

  • Dr. Sulima Fakeeh Hospital

    Jeddah, Mecca Region, 23717, Saudi Arabia

More trials for these conditions

Other studies related to the condition(s) this trial covers.